Rexahn Pharmaceuticals (REXN) Stock Fundamental Analysis

USA Nasdaq NASDAQ:REXN

1.81
-0.06 (-3.21%)
At close: Nov 5, 2020
1.75
-0.06 (-3.31%)
After Hours: 11/5/2020, 8:05:37 PM
No Fundamental Analysis report for REXN not available.

Rexahn Pharmaceuticals / REXN FAQ

What is the fundamental rating for REXN stock?

ChartMill assigns a fundamental rating of 2 / 10 to REXN.


What is the valuation status for REXN stock?

ChartMill assigns a valuation rating of 2 / 10 to Rexahn Pharmaceuticals (REXN). This can be considered as Overvalued.


What is the profitability of REXN stock?

Rexahn Pharmaceuticals (REXN) has a profitability rating of 1 / 10.